06.11.2025 • NewsClariantjoint ventureFlame Retardant

Clariant Announces Joint Venture for Flame Retardants with Fuhua

The joint venture, pending authorities' approval, will create halogen-free flame retardants
for various end-markets, addressing tightening regulatory requirements.

Clariant, a sustainability-focused specialty chemical company, announced its strategic joint venture with Fuhua, focused on developing innovative non-halogenated flame retardants. The new initiative, which is subject to customary approval from relevant authorities, aims to create next-generation phosphorus-based flame retardants to serve several industries like building and construction, automotive, electric and electronic, directly addressing the tightening technical and regulatory environment in these sectors.

The signing of this strategic joint venture agreement is the result of Clariant and Fuhua's joint innovation and R&D strategic cooperation. This strategic cooperation fully leverages the advantages and strengths of both Clariant and Fuhua. Clariant and Fuhua join in the commitment to develop new non-halogen flame retardants, adding significant value for their customers. Navigating through the evolving regulatory landscape and responding to their customers' increasingly ambitious sustainability objectives, the new joint venture will strategically position itself to transform the challenges into targeted innovation opportunities. This approach is deliberate and focused on creating sustainable value with new phosphorus-based products that maintain or improve flame-retardant performance while meeting regulatory requirements.

"This joint venture marks an important step in our commitment to developing flame retardants that solve both performance needs and regulatory concerns," said Angela Cackovich, Business President, Adsorbents & Additives and EMEA, Member of the Executive Steering Committee. “By partnering with Fuhua, a recognized leader in integrated chemical manufacturing, we're combining expertise to create solutions that will help our customers stay ahead of regulatory changes while maintaining the highest performance standards."

Company representatives
Clariant announces joint venture for novel flame retardants with Fuhua.
© Clariant

The new development initiative comes as regulatory bodies worldwide are implementing stricter controls on traditional flame-retardant technologies. Clariant's proactive approach enables the company to anticipate these changes and develop compliant alternatives before customers face regulatory challenges, reinforcing the company's reputation for forward-thinking innovation in specialty chemicals.

"This strategic cooperation demonstrates Clariant's targeted approach to innovation in the additives sector, consistently delivering solutions that address emerging challenges," said Manuel Mueller, Head of Strategy & Innovation, Clariant. "The new partnership with Fuhua represents another important step in developing products that align with Clariant's commitment to innovation, sustainability, regulatory compliance, and performance excellence."

This latest investment builds upon Clariant's established presence in China, following the CHF 100 million investment in its Daya Bay facility with a second production line for Exolit OP flame retardants. The company also expanded its capabilities with a second production line for Nylostab S-EED stabilizer in Cangzhou.

Company

Logo:

Clariant International Ltd

Rothausstr. 61
CH-4132 Muttenz
Switzerland

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read